1h Free Analyst Time
The MiRNA market is forecasted to grow by USD 2,020.12 mn during 2022-2027, accelerating at a CAGR of 18.91% during the forecast period. The report on the MiRNA market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of neurological disorders, significant scientific progress in MiRNA approach, and high heterogeneity of methodologies associated with MiRNA.
The MiRNA market is segmented as below:
By Type
- Consumables
- Instruments
By End-user
- Academic and government research institutes
- Biotechnology and pharmaceutical companies
- CROs and clinical diagnostic centers
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the MiRNA market covers the following areas:
- MiRNA market sizing
- MiRNA market forecast
- MiRNA market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global MiRNA market: BioGenex Laboratories Inc., BioVendor Laboratorni medicina AS, GeneCopoeia Inc., Genelinx International Inc., HEIM BIOTEK, Illumina Inc., InteRNA Technologies B.V., Merck KGaA, NanoString Technologies Inc., New England Biolabs Inc., OriGene Technologies Inc., PerkinElmer Inc., QIAGEN NV, Quantabio, Regulus Therapeutics Inc., SeqMatic LLC, Takara Bio Inc., TAMiRNA GmbH, Thermo Fisher Scientific Inc., and Miltenyi Biotec B.V. and Co. KG.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is increasing number of partnerships and collaborations of market vendors.'
According to the report, one of the major drivers for this market is the increasing prevalence of neurological disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- BioGenex Laboratories Inc.
- BioVendor Laboratorni medicina AS
- GeneCopoeia Inc.
- Genelinx International Inc.
- HEIM BIOTEK
- Illumina Inc.
- InteRNA Technologies B.V.
- Merck KGaA
- NanoString Technologies Inc.
- New England Biolabs Inc.
- OriGene Technologies Inc.
- PerkinElmer Inc.
- QIAGEN NV
- Quantabio
- Regulus Therapeutics Inc.
- SeqMatic LLC
- Takara Bio Inc.
- TAmiRNA GmbH
- Thermo Fisher Scientific Inc.
- Miltenyi Biotec B.V. and Co. KG
